Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Jennifer Dunsmore, Eilidh Duncan, Sara J. MacLennan, James N'Dow, Philip Cornford, Francesco Esperto, Nicola Pavan, María J. Ribal, Monique J. Roobol, Ted A. Skolarus, Steven MacLennan
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867012608150732800
author Jennifer Dunsmore
Eilidh Duncan
Sara J. MacLennan
James N'Dow
Philip Cornford
Francesco Esperto
Nicola Pavan
María J. Ribal
Monique J. Roobol
Ted A. Skolarus
Steven MacLennan
author_facet Jennifer Dunsmore
Eilidh Duncan
Sara J. MacLennan
James N'Dow
Philip Cornford
Francesco Esperto
Nicola Pavan
María J. Ribal
Monique J. Roobol
Ted A. Skolarus
Steven MacLennan
Jennifer Dunsmore
Eilidh Duncan
Sara J. MacLennan
James N'Dow
Philip Cornford
Francesco Esperto
Nicola Pavan
María J. Ribal
Monique J. Roobol
Ted A. Skolarus
Steven MacLennan
collection Wiley Open Access
contents Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer Jennifer Dunsmore Eilidh Duncan Sara J. MacLennan James N'Dow Philip Cornford Francesco Esperto Nicola Pavan María J. Ribal Monique J. Roobol Ted A. Skolarus Steven MacLennan BJUI Compass Abstract Objectives To understand how best to further reduce the inappropriate use of pre‐surgical androgen deprivation therapy (ADT), we investigated the determinants (influences) of ADT prescribing in urologists in two European countries using an established behavioural science approach. Additionally, we sought to understand how resource limitations caused by COVID‐19 influenced this practice. Identification of key determinants, of undistributed and disrupted practice, will aid development of future strategies to reduce inappropriate ADT prescribing in current and future resource‐limited settings. Participants and Methods We conducted semi‐structured qualitative interviews with urologists practicing in Italy and the UK from February to July 2022. Interviews focussed on undisrupted (usual) practice and disrupted practice (changes made during COVID‐19 restrictions). Codes were generated inductively and were mapped to the 14 domains of the Theoretical Domains Framework. Relevant domains of influence were identified, and the similarities and differences between the UK and Italy were distinguished. Results We identified 10 domains that were influential to ADT prescribing in the UK and eight in Italy. The role of guidance and evidence, the cancer care setting, the patients and the urologist's beliefs and experiences were identified as areas that were influential to ADT prescribing before surgery. Twenty‐one similarities and 22 differences between the UK and Italy, for usual and COVID‐19 practice, were identified across these 10 domains. Conclusion Similarities and differences influencing ADT prescribing prior to surgery should be considered in behavioural strategy development and tailoring to reduce inappropriate ADT use. We gained an understanding of usual, undistributed care and resource‐limited or disrupted care due to COVID‐19 in two European countries. This gives an indication of how influences on ADT prescribing may change in future resource‐limited circumstances and where efforts can be focused now and in future. 10.1002/bco2.411 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/bco2.411
format Artículo Open Access
id wiley_oa_10_1002_bco2_411
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
Jennifer Dunsmore
Eilidh Duncan
Sara J. MacLennan
James N'Dow
Philip Cornford
Francesco Esperto
Nicola Pavan
María J. Ribal
Monique J. Roobol
Ted A. Skolarus
Steven MacLennan
BJUI Compass
Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer Jennifer Dunsmore Eilidh Duncan Sara J. MacLennan James N'Dow Philip Cornford Francesco Esperto Nicola Pavan María J. Ribal Monique J. Roobol Ted A. Skolarus Steven MacLennan BJUI Compass Abstract Objectives To understand how best to further reduce the inappropriate use of pre‐surgical androgen deprivation therapy (ADT), we investigated the determinants (influences) of ADT prescribing in urologists in two European countries using an established behavioural science approach. Additionally, we sought to understand how resource limitations caused by COVID‐19 influenced this practice. Identification of key determinants, of undistributed and disrupted practice, will aid development of future strategies to reduce inappropriate ADT prescribing in current and future resource‐limited settings. Participants and Methods We conducted semi‐structured qualitative interviews with urologists practicing in Italy and the UK from February to July 2022. Interviews focussed on undisrupted (usual) practice and disrupted practice (changes made during COVID‐19 restrictions). Codes were generated inductively and were mapped to the 14 domains of the Theoretical Domains Framework. Relevant domains of influence were identified, and the similarities and differences between the UK and Italy were distinguished. Results We identified 10 domains that were influential to ADT prescribing in the UK and eight in Italy. The role of guidance and evidence, the cancer care setting, the patients and the urologist's beliefs and experiences were identified as areas that were influential to ADT prescribing before surgery. Twenty‐one similarities and 22 differences between the UK and Italy, for usual and COVID‐19 practice, were identified across these 10 domains. Conclusion Similarities and differences influencing ADT prescribing prior to surgery should be considered in behavioural strategy development and tailoring to reduce inappropriate ADT use. We gained an understanding of usual, undistributed care and resource‐limited or disrupted care due to COVID‐19 in two European countries. This gives an indication of how influences on ADT prescribing may change in future resource‐limited circumstances and where efforts can be focused now and in future. 10.1002/bco2.411 http://creativecommons.org/licenses/by/4.0/
title Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
topic BJUI Compass
url https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.411